Effects of Endocrine-Disrupting Chemicals on Obesity and Diabetes

被引:1
|
作者
Cander, Soner [1 ]
Yetkin, Ilhan [2 ]
机构
[1] Bursa Uludag Univ, Dept Endocrinol & Metab, Bursa, Turkiye
[2] Gazi Univ, Dept Endocrinol & Metab, Ankara, Turkiye
来源
ENDOCRINOLOGY RESEARCH AND PRACTICE | 2023年 / 27卷 / 04期
关键词
Diabetes; EDC; endocrine-disrupting chemicals; metabolic syndrome; obesity; BISPHENOL-A; ORGANOTIN COMPOUNDS; METABOLIC SYNDROME; ADIPOSE-TISSUE; HUMAN HEALTH; STEM-CELLS; TRIBUTYLTIN; INSULIN; EXPOSURE; ADIPOGENESIS;
D O I
10.5152/erp.2023.23309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increasing incidence of obesity and type 2 diabetes mellitus (T2DM) is a global problem. Although the obesity epidemic is mostly associated with a lack of physical activity and diet, several chemicals have been demonstrated to have a potential role in its pathophysiological mechanisms. An accumulating volume of evidence indicates that a subclass of endocrine-disrupting chemicals (EDCs) can impair hormonally regulated metabolic processes, particularly in the case of exposure early in life when the defense mechanisms of the human body are yet to be fully developed. These chemicals are called "obesogenic EDCs" and might cause some people to gain weight despite their attempts to increase physical activity and limit calorie intake. Similarly, background exposure to some environmental EDCs has been associated with diabetes and impaired glucose metabolism. Certain widespread EDCs, including pesticides, dioxins, and bisphenol A, in animal models may change beta function and insulin resistance. These EDCs, which may accumulate in adipose tissue and cause a pro-inflammatory response, can also be found at measurable levels in human blood and can either imitate or block some hormonal reactions. In this review, we evaluate EDCs in relation to obesity and T2DM in light of the current literature.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 50 条
  • [41] Endocrine-disrupting chemicals and male health
    Minguez-Alaron, Lidia
    Gaskins, Audrey J.
    Meeker, John D.
    Braun, Joseph M.
    Chavarro, Jorge E.
    FERTILITY AND STERILITY, 2023, 120 (06) : 1138 - 1149
  • [42] The economic legacy of endocrine-disrupting chemicals
    La Merrill, Michele A.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (12): : 961 - 962
  • [43] Endocrine-Disrupting Chemicals and Child Health
    Ghassabian, Akhgar
    Vandenberg, Laura
    Kannan, Kurunthachalam
    Trasande, Leonardo
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 573 - 594
  • [44] Endocrine-disrupting chemicals in marine environment
    Preston, MR
    CHEMISTRY OF MARINE WATER AND SEDIMENTS, 2002, : 309 - 324
  • [45] Endocrine-Disrupting Chemicals: Introduction to the Theme
    Lisco, Giuseppe
    Giagulli, Vito Angelo
    Iovino, Michele
    Guastamacchia, Edoardo
    De Pergola, Giovanni
    Triggiani, Vincenzo
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (07) : 677 - 685
  • [46] The challenge posed by endocrine-disrupting chemicals
    Ashby, J
    Houthoff, E
    Kennedy, SJ
    Stevens, J
    Bars, R
    Jekat, FW
    Campbell, P
    VanMiller, J
    Carpanini, FM
    Randall, GLP
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 (02) : 164 - 169
  • [47] Endocrine-Disrupting Chemicals in Cosmetics Reply
    Rubin, Courtney Blair
    Brod, Bruce A.
    JAMA DERMATOLOGY, 2020, 156 (05) : 604 - 604
  • [48] Endocrine-disrupting chemicals and child health
    Kiess, Wieland
    Haeussler, Gabriele
    Vogel, Mandy
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (05)
  • [49] Endocrine-disrupting chemicals and skin manifestations
    Ju, Qiang
    Zouboulis, Christos C.
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2016, 17 (03): : 449 - 457
  • [50] Endocrine-disrupting chemicals and skin manifestations
    Qiang Ju
    Christos C. Zouboulis
    Reviews in Endocrine and Metabolic Disorders, 2016, 17 : 449 - 457